SITAGLIPTIN/METFORMIN GRINDEKS 50 mg/850 mg Rumunia - rumuński - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sitagliptin/metformin grindeks 50 mg/850 mg

as grindeks. - letonia - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/850mg - analogi ai glp-1 combinatii de antidiabetice orale

Sitagliptin / Metformin hydrochloride Accord Unia Europejska - rumuński - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , terapie triplă) ca adjuvant la dietă și exercițiu fizic, la pacienți controlați inadecvat cu doza maximă tolerată de metformin și o sulfoniluree. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

LONAMO DUO 50 mg/850 mg Rumunia - rumuński - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lonamo duo 50 mg/850 mg

galenicum health s.l. - spania - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/850mg - analogi ai glp-1 combinatii de antidiabetice orale

SITAGLIPTINA/METFORMIN DR. REDDY'S 50 mg/1000 mg Rumunia - rumuński - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sitagliptina/metformin dr. reddy's 50 mg/1000 mg

betapharm arzneimittel gmbh - germania - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/1000mg - analogi ai glp-1 combinatii de antidiabetice orale

SITAGLIPTINA/METFORMIN DR. REDDY'S 50 mg/850 mg Rumunia - rumuński - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sitagliptina/metformin dr. reddy's 50 mg/850 mg

betapharm arzneimittel gmbh - germania - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/850mg - analogi ai glp-1 combinatii de antidiabetice orale

JANSITIN DUO 50 mg/850 mg Rumunia - rumuński - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

jansitin duo 50 mg/850 mg

sag manufacturing s.l.u. - spania - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/850mg - analogi ai glp-1 combinatii de antidiabetice orale

EPROCLIV 50 mg/1000 mg Rumunia - rumuński - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

eprocliv 50 mg/1000 mg

lek d.d. - slovenia - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/1000mg - analogi ai glp-1 combinatii de antidiabetice orale

Sitagliptin / Metformin hydrochloride Sun Unia Europejska - rumuński - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , terapie triplă) ca adjuvant la dietă și exercițiu fizic, la pacienți controlați inadecvat cu doza maximă tolerată de metformin și o sulfoniluree. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

JANUMET 50 mg/1000 mg Rumunia - rumuński - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

janumet 50 mg/1000 mg

merck sharp & dohme b.v. - olanda - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/1000mg - antidiabetice orale si parenerale, exclusiv insuline combinatii de antidiabetice orale

SITAGLIPTIN/CLORHIDRAT DE METFORMIN SUN 50 mg/1000 mg Rumunia - rumuński - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sitagliptin/clorhidrat de metformin sun 50 mg/1000 mg

sun pharmaceutical industries (europe) b.v. - olanda - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/1000mg - analogi ai glp-1 combinatii de antidiabetice orale